R.P. Scherer Corp offering 1.6 mln share 5-3/4 pct convertible exchangeable prefer stock 25 dlrs share. Each stock convertible company's common stock 23.60 dlrs share represent conversion premium 24.2 pct sale price 19 dlrs share March 11. Goldman Sachs Co lead underwriter offering. Scherer director Richard Manoogian buy 200000 share prefer stock 25 dlrs share. The company proceeds corporate purpose include funding increase commitment research development drug formulation delivery systems. Reuter 